The malignant disease now named after him was first described by Moritz Kaposi (Figure 1 ) in 1872 in a paper entitled 'Idiopathic multiple pigmented sarcoma of the skin'1. He described the characteristics of the disease as follows: ' Nodules the size of shot, peas or hazelnuts and brown-red to blue-red in colour develop in the skin without a known general or local cause. Their surface is smooth, their consistency coarse-elastic; they sometimes swell like an angioma. They are either isolated and then protrude, after becoming larger, in a spherical shape, or else they form groups and remain flatter. In the latter case, the central nodules of a plaque retrogress and generate a pitted, darkpigmented depression there. They ordinarily appear first on the sole of the foot and the instep; and not long afterwards, also on the hands. The largest numbers generally develop on these parts of the body, where they are accompanied by diffuse thickening of the skin and deformation of the hands and feet.
During the further progress of the disease, isolated nodules and groups of nodules also appear on the arms, legs, face and trunk, but in smaller numbers and irregular patterns.
Some of the nodules may also atrophy and regress. It seems that they ulcerate only at a later time or, more correctly, gangrene develops in their place.
The lymph glands do not swell substantially.
Finally the identical nodules appear on the mucous linings of the larynx, trachea, stomach, and intestines (in particularly large numbers in the large intestine down to the rectum), and other nodules form on the liver.... ... the striking pigmentation is caused, perhaps entirely but certainly preponderantly, by the large amount of blood and the haemorrhages within the nodules.
While it is quite possible that a carcinoma exists for a time locally and that a general carcinomatosis develops from it by metastasis, we must assume with regard to the present ailment that a general disease (dyscrasia) exists from the beginning...' 0141-0786/86/ 090532-03/$02.00/0 01986 The Royal Society of Medicine Whilst Kaposi's original description is still largely valid, greater knowledge of the different clinical presentations of this uncommon malignancy now permits it to be divided chronologically into four types: (1) an indolent form described by Kaposi, which may now be termed 'European' or 'western' or 'nodular'; (2) a florid and more aggressive form, first described during the 1950s from equatorial Africa; (3) a form which manifested in the 1970s in transplant patients and in others receiving immunosuppressive therapy; (4) the most recent form, reported since 1981 in patients with the acquired immune deficiency syndrome (AIDS).
Although the clinical presentation and the course of disease vary, the histological appearance of skin lesions in all types of KS is similar. On microscopy there are proliferations of spindle cells and of small blood vessels, formation of vascular slits filled European or western KS The European or western or nodular form of KS occurs chiefly in males in their sixth or seventh decades. The male to female ratio is about 10: 1. There may be an increased incidence among southern and eastern Europeans, among people from the Mediterranean littoral and among their descendants in north America. In this form of the disease the lesions first appear, as Kaposi found, on the lower legs. There are macules, then papules and nodules.
Ulceration may occur, but lymphadenopathy is uncommon. The course of the disease is often slow, average survival being 8-13 years after diagnosis. In a few patients the disease may be locally aggressive with fungating growths and bone involvement. Disease which spreads rapidly to involve many areas of skin, lymph nodes and viscera has been rare in Europeans; when it does occur it is usually fatal within a few years -'. Immune disorders are not usually associated with this type of Kaposi's sarcoma. High titres to cytomegalovirus (CMV) have occasionally been demonstrated. Interestingly, the incidence of second primaries in patients with KS, especially lymphoreticular neoplasms, is rather high6.
African KS
The second form of the disease, the so-called African KS, occurs in equatorial and southern Africa where its incidence may be 200 times greater than that seen in western Europe and North America. African KS has doubtless been in existence for a long time but was first reported in English language medical journals in the 1950s by authors who worked in central Africa. Its geographical distribution is similar to that of African Burkitt's lymphoma. The male preponderance persists, although the disease occurs in younger adult patients and may even be found in children. About 10% of patients present with widespread lymphadenopathy and few skin lesions. This disseminated form of the disease pursues a fulminant course and is usually fatal within three years7"8. There have been some reports of defects in cell-mediated immunity ofpatients with KS in Uganda. Herpes-type viral particles have been observed in tissue cultures from African patients with KS9'10. Of interest is the fact that KS is rare among whites and Asians living in Africa and among negroes in the USA.
KS associated with immunosuppressive therapy
The third form of KS attracted attention during the 1970s, occurring in patients who were being treated with immunosuppressive drugs. Renal transplant patients who receive both prednisone and azathioprine seem to be particularly susceptible. However, the disease has also been reported in patients on immunosuppressive drugs for a variety of other conditions, for example temporal arteritis. It may remain localized to the skin but more frequently is disseminated and involves the viscera. Ifthe immunosuppressive agents are reduced or discontinued the KS may regress partially or even completely, although a few cases have been reported where the tumour has progressed despite withdrawal of azathioprine' 1.12 AIDS-related KS The fourth form has manifested very recently and rather suddenly. It is found in association with AIDS, chiefly in homosexual men in the largest cities of the USA and, to a lesser extent, of western Europe. Some cases have been reported in women and in heterosexual men.
The cutaneous lesions usually present on head, trunk and arms as hyperpigmented macules and papules of variable size and number. Systemic complaints, especially fever, malaise and weight loss, are common. The mucosa of bronchi and of gastrointestinal tract may be affected. Lymphadenopathy is frequently present. In this adult group, KS is often associated with opportunistic infections found in AIDS, such as Pneumocystis carinii, herpes simplex virus, cytomegalovirus, toxoplasma, cryptococcus, mycobacterium and candida. Pneumnocystis carinii pneumonia had not been reported previously in association with KS. Mortality in this form of KS is high, sometimes because of widespread visceral involvement, frequently because of debilitating infections.
Laboratory investigations have demonstrated elevated serum immunoglobulins. There are antibody titres to Epstein-Barr virus and to cytomegalovirus, both members ofthe DNA herpesvirus group. There is persistent impaired cellular immunity, as measured by delayed cutaneous hypersensitivity. The numbers of helper T-lymphocytes are reduced and the ratio of helper to suppressor T-lymphocytes is reversed. The syndrome of immunological abnormalities in these AIDS patients has been attributed to infection with an RNA retrovirus, namely HITLV-IJI (human T-cell lymphotrophic virus type III) or LAV (lymphadenopathy-associated virus) or ARV (AIDSrelated virus)13 17 
Treatment
Kaposi's sarcoma is a very radioresponsive tumour, and before the advent of radiotherapy little useful treatment was available. After the administration of radiotherapy, lesions regress at variable rates; brown pigmentation from haemorrhage may remain permanently at the sites of lesions. Doses of radiation required to cure cutaneous lesions are modest"8-20* Chemotherapy, either single agent or multi-drug, should be reserved for the treatment of generalized KS. The drugs more commonly used have been vinblastine, actinomycin D, adriamycin and dacarbazine, but it is uncertain which are best. AIDS patients have sometimes been treated with interferon but this has achieved only slight success21. These patients are at high risk from fatal opportunistic infections as well as from KS. Chemotherapy may worsen their 22 immunosuppression while destroying the tumour .
The two most recent forms of Kaposi's sarcoma both occur in people with immunological abnormalities. It is, of course, the AIDS-related fourth form which, because of the passions and publicity associated with AIDS, has aroused recent interest in this tumour.
